← All organizations

National Research Council, Italy

Government

Also known as: Institute of Biomedical Technologies-National Research Council, Italy

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 1, 2021

Timeline

No events for the selected filters.

Drugs by trial phase (3 distinct, 2 trials)

Phase 3 (1 own, 0 via acquisition)

paricalcitol

Other trials (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (2)

NCT06005506Lead sponsorN/AOct 1, 2021
NCT01680198Reponsible party - principal investigatorPhase 3Jun 1, 2011

Details

Last known activity: Oct 1, 2021